Certara stock.

The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Specialized modules are: Simcyp Pediatric. Simcyp® Pediatric Simulator is the industry’s most sophisticated technology for modeling drug performance and determining dosing in neonates, infants, and children. The Simulator contains extensive libraries on demographics, developmental physiology, and the ontogeny of drug elimination pathways.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comNov 24, 2023 · See the latest Certara Inc Ordinary Shares stock price (700:XBER), related news, valuation, dividends and more to help you make your investing decisions.

Contact Us U.S. markets open in 9 hours 29 minutes S&P Futures 4,574.25 -2.50(-0.05%) Dow Futures 36,033.00 +23.00(+0.06%) Nasdaq Futures 15,955.50 -30.00(-0.19%) …Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

The estimated Net Worth of Michael Andrew Schemick is at least $24.7 Million dollars as of 31 March 2023. Michael Schemick owns over 13,302 units of Certara stock worth over $12,184,118 and over the last 4 years …According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.

Mar 10, 2023 · Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%. Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Certara stock ( CERT) appears to check all the boxes. Nominated by one of our lovely subscribers, the New Jerzee-based company serves the drug development industry by offering software and services around its biosimulation platform. It claims to compete indirectly with companies like Schrödinger ( SDGR ), which uses a …Certara, Inc. (NASDAQ:CERT) Market Cap: $2.3B Certara, Inc. (NASDAQ:CERT) offers software products for using bio-simulation in drug discovery, preclinical and clinical research.According to 7 stock analysts, the average 12-month stock price forecast for Certara stock is $50.29, which predicts an increase of 240.60%. The lowest target is $16 and the highest is $235. On average, analysts rate Certara stock as a buy.

Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.

Matthew Walsh CERT stock SEC Form 4 insiders trading. Matthew has made over 12 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently Matthew exercised 9,067 units of CERT stock worth $135,642 on 17 May 2023.. The largest trade Matthew's ever made was exercising 102,043 units of …

Certara Inc Stock Price History. Certara Inc’s price is currently up 18.87% so far this month. During the month of November, Certara Inc’s stock price has reached a high of $14.58 and a low of $11.81. Over the last year, Certara Inc has hit prices as high as $24.96 and as low as $11.81. Year to date, Certara Inc’s stock is down 49.01%.Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...Nov 17, 2021 · November 17, 2021. PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share. What is the support and resistance for Certara (CERT) stock price? CERT support price is $14.50 and resistance is $15.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT stock …Mar 14, 2023 · Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ... Aug 12, 2022 · Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ... New metrics and analytics capabilities enable informed decision making for biopharmaceutical clientsPRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...

Certara, Inc. (NASDAQ:CERT) Market Cap: $2.3B Certara, Inc. (NASDAQ:CERT) offers software products for using bio-simulation in drug discovery, preclinical and clinical research.Robert has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,646 units of CERT stock worth $166,436 on 31 March 2023.A Barchart Premier membership lets you screen on these options using advanced filters, including strategies for Covered Calls, Naked Puts and Option Spreads ...Certara, Inc. (CERT) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.01 per share a year ago.PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...Certara, Inc. (CERT) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.01 per share a year ago.

Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ...13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.

11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...11 Jan 2022 ... Get Certara Inc (CERT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... Find the latest EngageSmart, Inc. (ESMT) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Price Forecast Suggests 35.97% Upside. As of October 4, 2023, the average one-year price target for Certara is 19.53. The forecasts range from a low of 16.16 to a high of $25.20. The ...Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensDrayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $54,863 on 31 March 2023.3,990 units of CERT stock worth $54,863 on 31 March 2023.Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.

Find the latest Oshkosh Corporation (OSK) stock quote, history, news and other vital information to help you with your stock trading and investing.

New metrics and analytics capabilities enable informed decision making for biopharmaceutical clientsPRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...

Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to the Certara Third Quarter 2023 Earnings Conference Call. [Operator Instructions] ... Stock Certara, Inc. - Nasdaq . News Certara, Inc. Transcript : Certara, Inc., Q3 2023 Earnings Call, Nov 08, 2023. CATEGORIES. Indexes; Equities ...Q3 2023 Certara Inc Earnings Call. Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …Nov 14, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 14, 2023, 4:00 PM, CST, Certara Inc’s stock price was $14.49. Certara Inc is up 11.29% from its previous closing price of $13.02. During the last market session, Certara Inc’s stock traded between $12.99 and $13.66. Currently, there are 159.17 million shares of Certara Inc stock ... The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development.Current stock price of Certara, Inc. (CERT) online. Stock quotes and charts for Certara, Inc. (CERT) on the website of Just2Trade broker.Certara is the leading provider of mechanistic modeling software and consulting services, predicting outcomes for the global biopharm industry. The groundbreaking Simcyp Simulator is relied upon by pharmaceutical and biotech companies, academia and regulatory agencies, including the US FDA. Simcyp is committed to using technology and innovation ...Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile. Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock ...Mar 14, 2023 · Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ...

Fisker stock price target cut to $1 from $2, strong sell rating reiterated at CFRA. Nov. 14, 2023 at 6:30 a.m. ET by Tomi Kilgore.Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Real time Certara (CERT) stock price quote, stock graph, news & analysis.Instagram:https://instagram. 6th district parisawinw stockwhat to look for on quarterscobalt investing Success is Achieved Together. Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services. Starting January 1, 2020, all regulatory transactions for Master Files prepared in the non-eCTD format must be sent via the Common Electronic Submission Gateway (CESG). We have seen a spike in these types of submissions. The CESG has been in operation at Health Canada since February 2014, and it provides a secure and prompt … dow return ytdishares transportation What is the target price for Certara (CERT) stock? A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a ... vangaurd voo Aug 11, 2022 · In connection with the offering, the Selling Stockholders have granted the underwriter a 30-day option to purchase up to 1,050,000 additional shares. No shares are being sold by Certara. The Selling Stockholders will receive all of the proceeds from this offering. The last reported sale price of Certara’s common stock on August 11, 2022 was ... Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.